Matches in UGent Biblio for { <https://biblio.ugent.be/publication/3029136#aggregation> ?p ?o. }
Showing items 1 to 43 of
43
with 100 items per page.
- aggregation classification "A1".
- aggregation creator B239382.
- aggregation creator B239383.
- aggregation creator B239384.
- aggregation creator B239385.
- aggregation creator B239386.
- aggregation creator B239387.
- aggregation creator B239388.
- aggregation creator B239389.
- aggregation creator B239390.
- aggregation creator person.
- aggregation creator person.
- aggregation creator person.
- aggregation date "2012".
- aggregation format "application/pdf".
- aggregation hasFormat 3029136.bibtex.
- aggregation hasFormat 3029136.csv.
- aggregation hasFormat 3029136.dc.
- aggregation hasFormat 3029136.didl.
- aggregation hasFormat 3029136.doc.
- aggregation hasFormat 3029136.json.
- aggregation hasFormat 3029136.mets.
- aggregation hasFormat 3029136.mods.
- aggregation hasFormat 3029136.rdf.
- aggregation hasFormat 3029136.ris.
- aggregation hasFormat 3029136.txt.
- aggregation hasFormat 3029136.xls.
- aggregation hasFormat 3029136.yaml.
- aggregation isPartOf urn:issn:0179-7158.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "Radiation-induced oesophagitis in lung cancer patients: is susceptibility for neutropenia a risk factor?".
- aggregation abstract "Radiation-induced oesophagitis is a major side effect of concurrent chemotherapy and radiotherapy. A strong association between neutropenia and oesophagitis was previously shown, but external validation and further elucidation of the possible mechanisms are lacking. A total of 119 patients were included at two institutions. The concurrent group comprised 34 SCLC patients treated with concurrent carboplatin and etoposide, and concurrent chest irradiation, and 36 NSCLC patients with concurrent cisplatin and etoposide, and concurrent radiotherapy, while the sequential group comprised 49 NSCLC patients received sequential cisplatin and gemcitabine, and radiotherapy. Severe neutropenia was very frequent during concurrent chemoradiation (grade: 4 41.4%) and during induction chemotherapy in sequentially treated patients (grade 4: 30.6%), but not during radiotherapy (only 4% grade 1). In the concurrent group, the odds ratios of grade 3 oesophagitis vs. neutropenia were the following: grade 2 vs. grade 0/1: 5.60 (95% CI 1.55-20.26), p = 0.009; grade 3 vs. grade 0/1: 10.40 (95% CI 3.19-33.95); p = 0.0001; grade 4 vs. grade 0/1: 12.60 (95% CI 4.36-36.43); p < 0.00001. There was no correlation between the occurrence of neutropenia during induction chemotherapy and acute oesophagitis during or after radiotherapy alone. In the univariate analysis, total radiation dose (p < 0.001), overall treatment time of radiotherapy (p < 0.001), mean oesophageal dose (p = 0.038) and neutropenia (p < 0.001) were significantly associated with the development of oesophagitis. In a multivariate analysis, only neutropenia remained significant (p = 0.023). We confirm that neutropenia is independently correlated with oesophagitis in concurrent chemoradiation, but that the susceptibility for chemotherapy-induced neutropenia is not associated with radiation-induced oesophagitis. Further studies focusing on the underlying mechanisms are thus warranted.".
- aggregation authorList BK511172.
- aggregation endPage "567".
- aggregation issue "7".
- aggregation startPage "564".
- aggregation volume "188".
- aggregation aggregates 3029150.
- aggregation isDescribedBy 3029136.
- aggregation similarTo s00066-012-0098-z.
- aggregation similarTo LU-3029136.